084440 — U Bion Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapNeutral

Annual income statement for U Bion Co, fiscal year end - September 30th, KRW millions except per share, conversion factor applied.

	2019 September 30th	R2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS/A	Annual Audited Accounts	Interim Report	Annual Audited Accounts	Annual Audited Accounts
Standards:	KAS	IFRS	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	18,675	22,646	28,067	31,461	31,832
Cost of Revenue
Gross Profit	8,393	9,965	12,120	14,369	13,174
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	18,390	21,370	26,343	29,116	31,450
Operating Profit	285	1,276	1,724	2,345	381
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	477	84.4	1,440	1,974	-748
Provision for Income Taxes
Net Income After Taxes	435	36.3	1,441	2,151	-601
Minority Interest
Net Income Before Extraordinary Items
Net Income	435	36.3	1,441	2,151	-544
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	386	36.3	1,441	2,151	-544
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.283	7.73	96.1	128	-27.5
Dividends per Share